Lexeo Therapeutics, Inc.·4

Nov 20, 5:18 PM ET

Robertson Jenny 4

4 · Lexeo Therapeutics, Inc. · Filed Nov 20, 2025

Insider Transaction Report

Form 4
Period: 2025-11-18
Robertson Jenny
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2025-11-18$9.27/sh549$5,08968,381 total
Footnotes (3)
  • [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
  • [F2]This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
  • [F3]Includes 49,607 RSUs.

Documents

1 file
  • 4
    form4-11202025_101103.xmlPrimary